EODData

MEMBERSHIP REGISTER LOG IN

FRA, PHGN: Pharming Group NV

13 Feb 2026
LAST:

1.288

CHANGE:
 0.06		OPEN:
1.288		HIGH:
1.288		ASK:
0.000		VOLUME:
87
CHG(%):
4.66		PREV:
1.351		LOW:
1.288		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
13 Feb 261.2881.2881.2881.28887
11 Feb 261.3671.3671.3511.35187
10 Feb 261.3631.3631.3621.36210
09 Feb 261.3521.3521.3521.3522.1K
06 Feb 261.3831.3831.3661.3802.1K
05 Feb 261.4161.4291.4161.42911
04 Feb 261.4281.4281.4281.42830
03 Feb 261.5161.5161.5161.51630
02 Feb 261.7071.7071.4811.48130
30 Jan 261.7071.7071.7071.70730

PROFILE

Name:Pharming Group NV
About:Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company's lead product is RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K" inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. It has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.
Sector:Healthcare
Industry:Biotechnology
Address:Darwinweg 24, Leiden, Netherlands, 2333 CR
Website:https://www.pharming.com
ISIN:NL0010391025

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:56.95 
Forward P/E:-48.10 
PEG Ratio:-48.10 
Price to Sales:2.78 
Price to Book:3.22 
Profit Margin:0.00 
Operating Margin:0.27 
Return on Assets:0.06 
Return on Equity:0.00 
Revenue:307.75M 
EBITDA:12.2M 
Shares:685.15M 
Market Cap:882.47M 

TECHNICAL INDICATORS

MA5:1.354.5%
MA10:1.4311.0%
MA20:1.5318.7%
MA50:1.4815.2%
MA100:1.376.5%
MA200:1.1610.6%
RSI14:23.28 
WPR14:-100.00 
MTM14:-0.37
ROC14:-0.22 
ATR:0.05 
Week High:1.387.4%
Week Low:1.290.0%
Month High:1.7636.8%
Month Low:1.2910.6%
Year High:1.7636.8%
Year Low:0.6791.7%
Volatility:7.41 

RECENT SPLITS

Date Ratio
05 Mar 20131-10